Bondalti Acquires Ercros in EUR 247.5M Iberian Chemical Deal

Portuguese chemical powerhouse Bondalti has successfully concluded its acquisition of Spanish counterpart Ercros, marking a significant consolidation within the Iberian chemical sector. The transaction, valued at approximately EUR 247.5 million, saw a substantial 77.23% acceptance rate from Ercros shareholders, signaling strong endorsement for the strategic combination.

The deal's completion follows the Spanish National Securities Market Commission's (CNMV) approval on February 10, 2026. The offer period, which closed on March 14, 2026, attracted 70,615,637 shares, comfortably surpassing Bondalti's minimum acceptance threshold of 50% of Ercros's capital. This robust participation ensures the integration proceeds as planned, with settlement anticipated by March 26, 2026.

This strategic move is set to dramatically enhance Bondalti's market standing, effectively doubling its chlorine production capabilities to an estimated 450,000 tons annually. This expansion solidifies Bondalti's position as the preeminent chlor-alkali producer across the Iberian Peninsula. Ercros, with its network of Spanish facilities, contributes a diverse portfolio including chlorine, caustic soda, and PVC, vital components for numerous industrial applications.

While the majority of shareholders embraced the offer, certain significant stakeholders opted out. Notably, the Joan Casas Galofre family, collectively holding 10.8% of Ercros, did not tender their shares. In contrast, French financial institution Oddo BHF, which had amassed a 4.9% stake, chose to accept Bondalti's offer just two days prior to the deadline, underscoring the attractiveness of the terms presented.

The acquisition aligns with broader trends in the European chemical industry, which is experiencing a period of consolidation driven by the need for scale, efficiency, and enhanced competitive positioning in a global market. Companies are increasingly seeking to optimize their operations and expand their product offerings to meet evolving demand and navigate regulatory pressures. The chlor-alkali segment, in particular, is critical for downstream industries such as construction, automotive, and water treatment.

With the successful tender offer, Bondalti is now positioned to explore further integration steps. Subject to regulatory approvals, the company may initiate a delisting process for Ercros, offering the same EUR 3.505 per share price to remaining shareholders. This potential delisting would streamline Bondalti's corporate structure and fully integrate Ercros's operations into its broader strategic vision.

Bondalti's expansion into Spain through this acquisition represents a significant step in its growth trajectory. The company, already a major player in Portugal with interests spanning chemicals, water treatment, and agribusiness, is leveraging this deal to achieve greater market penetration and operational synergy. The combined entity is expected to benefit from economies of scale and a strengthened competitive advantage in the European chemical landscape.